Bicarbonate

Bicarbonate

SCHEMBL579108

CN1CCC(N(C)C(=O)c2ccc(Nc3ncc(C(F)(F)F)c(NC4CCCC4)n3)cc2)CC1.O=C(O)O

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 10/20 0.64
KIT P10721 9/20 0.64
AURKA O14965 2/20 0.64
EGFR P00533 1/20 0.64
NTRK1 P04629 1/20 0.64
CDK1 P06493 1/20 0.64
IGF1R P08069 1/20 0.64
EPHA1 P21709 1/20 0.64
CDK2 P24941 1/20 0.64
BMX P51813 1/20 0.64
JAK3 P52333 1/20 0.64
CDK6 Q00534 1/20 0.64
PAK1 Q13153 1/20 0.64
ALK Q9UM73 1/20 0.64
SYK P43405 3/20 0.59
AURKB Q96GD4 1/20 0.55
PTK2 Q05397 3/20 0.55
ULK1 O75385 3/20 0.54
PTK2B Q14289 1/20 0.53
ULK2 Q8IYT8 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL579262 0.98 KIT (0.64) FLT3KITAURKAEGFRNTRK1
SCHEMBL579261 0.91 FLT3 (0.61) FLT3KITAURKAEGFRNTRK1
SCHEMBL13808086 0.91 FLT3 (0.61) FLT3KITAURKAEGFRNTRK1
SCHEMBL579213 0.90 FLT3 (0.61) FLT3KITAURKAEGFRNTRK1
SCHEMBL12438917 0.90 FLT3 (0.61) FLT3KITAURKAEGFRNTRK1
SCHEMBL578941 0.89 FLT3 (0.57) FLT3KITAURKAEGFRNTRK1
SCHEMBL578940 0.89 FLT3 (0.57) FLT3KITAURKAEGFRNTRK1
SCHEMBL13808089 0.89 PTK2 (0.58) FLT3KITAURKAEGFRNTRK1
Bicarbonate SCHEMBL579271 0.88 AURKA (0.71) FLT3KITAURKAEGFRNTRK1
SCHEMBL13808170 0.88 FLT3 (0.59) FLT3KITAURKAEGFRNTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2027107-B1 2, 4 -DIAMINO PYRIMIDINES AS CELL CYCLE KINASE INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2012-02-15 EP disclosed
EP-1902037-B1 2,4-DIAMINO-PYRIMIDINES USED AS AURORA INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2009-09-02 EP disclosed